Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Social Media Campaign for Latin Lupus Sufferers

Vanessa Caceres  |  Issue: January 2018  |  January 19, 2018

 

A person living with lupus may feel isolated. They receive information from their doctor, but it’s never enough to fully understand the disease. So where do they turn? Social media, where they can connect, share information and learn.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A new social media initiative, Hablemos de Lupus—which translates to Let’s Talk About Lupus—focuses on sharing accurate lupus information with Spanish-speaking patients in Latin America. The focus on Latin America ties in with the proportionally larger number of Latino patients with lupus than non-Latinos. Research shows that a lupus diagnosis usually takes longer to confirm in Latinos than in non-Latinos and the disease tends to be more severe among Latinos.

“Hablemos de Lupus is part of a comprehensive project that aims to bridge a longstanding gap in the provision of appropriate and scalable health education to the Latin American population with lupus,” says Cristina Drenkard, MD, PhD, an associate professor of medicine in the Division of Rheumatology at Emory School of Medicine, Atlanta, who leads the initiative. “The first stage of this initiative targets the Spanish-speaking population with lupus and their caregivers.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Funded by a 2017 International League of Associations for Rheumatology grant, Hablemos de Lupus uses social media as its main vehicle. Its Facebook page has the largest concentration of users, but it also fields a YouTube channel and a Twitter account.

“The social channels provide a safe community where patients can learn from evidence-based content, express themselves, ask [experts] questions and open discussions around lupus with others,” Dr. Drenkard says.

Facebook appears key, says Celeste Eberhardt, social media specialist for Hablemos de Lupus. “Most people have Facebook access and connect to it often. … I was shocked by how relieved people were to see others going through similar experiences,” Ms. Eberhardt says.

The Content

Topics covered on Hablemos include general education about lupus and living better with lupus. Videos that last just a couple of minutes and short messages can convey evidence-based information. The group creates its content with the needs and health literacy levels of the audience in mind, Dr. Drenkard says.

Lupus sufferers can check out Hablemos de Lupus on Twitter, Facebook and YouTube.

There’s a special focus on making the videos easy for people to understand, so they aren’t too complex, Ms. Eberhardt says. Videos posted include: “What Is Lupus?” “What Is an Antibody?” and “Exercising with Lupus.” Followers can ask questions, and a team of Hablemos rheuma­tologists answer within 24 hours.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus ErythematosusTechnology Tagged with:LupusSocial MediaTechnology

Related Articles

    Navigating the Social Media Highway

    January 17, 2011

    Rheumatologists spot speed bumps, opportunities

    Patient Education Materials for Non-English Speakers

    July 10, 2023

    Recently, the Vasculitis Foundation, in collaboration with a group of physicians and vasculitis investigators in the U.S. and Latin America (i.e., Mexico, Colombia, Peru, Chile and Argentina), launched an educational series of videos in Spanish called, Aprendiendo de Vasculitis. “The goal of these videos is to provide education to all Spanish-speaking patients,” explains Sebastian E….

    Social Media Connects, Informs Rheumatologists

    April 26, 2018

    When Paul Sufka, MD, a rheumatologist with HealthPartners Medical Group and Regions Hospital in St. Paul, Minn., wants to connect with his colleagues or keep abreast of the latest rheumatology journal articles, he turns to Twitter. Dr. Sufka is one of many rheumatologists who have found effective ways to incorporate social media into their medical…

    How A Social Media Policy Can Protect Your Practice

    February 3, 2012

    While social media can be a beneficial marketing tool, it is important for rheumatologists to address the proper ways to use this outreach both inside and outside the workplace through a specific media policy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences